TrialAssure launches TrialResults.com
TrialAssure launches TrialResults.com TrialAssure, a global software company focused on developing clinical trial transparency tools, has announced the launch of TrialResults.com, a new portal for sponsors to publicly share plain language, or lay, summaries with clinical trial participants. This portal allows trial participants to access the plain language summaries in any region of the world and in their native language.
In place of mailing paper copies of the plain language summaries to participants, sponsors can upload the summary onto the portal.
Using TrialResults.com takes just three steps:
- Clinical research organizations and sponsors upload completed plain language summaries onto the portal
- Users enter the unique trial identifier that has been provided to them into the search bar
- The relevant plain language summary appears
Currently, only 2 percent of clinical trial sponsors have issued plain language summaries to participants in the past few years, as recently reported by Applied Clinical Trials.
“TrialResults.com comes at a crucial time in the pharmaceutical industry when the requirement for posting lay summaries is looming,” said Alan Nicolle, Director, Business Development & Business Alliance Partnerships at TrialAssure in London.
Learn more at www.trialresults.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
